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The  ~.11 light  chain  is  encoded  by  a  single  germ-line  vx~  and  cx~  gene.  Upon 
committment, the vx~ gene is translocated in cis to a transcription unit which includes 
the ca: gene separated from vxa by a nontranslated stretch of some  1,250 nucleotides 
(intron)  (1). This unit is then transcribed as the high molecular weight nuclear RNA 
(HnRHA)  which must be processed by excision of the intron to yield the polysome- 
bound mRNA in which the coding of vxaand  cxamust be contiguous  (2, 3). 
The  vx~  germ-line  gene  complemented  with  a  set  of closely-related  heavy  chain 
variable  region  (vn)  germ-line  genes  (referred  to  as  v~,~;  a))  encodes  the  anti- 
a(1,3) dextran specificity of high responder strains of mice. The role of the v"~l~  'a~ genes 
in the  anti-a(1,3)  response has been extensively  studied  (4).  Here we deal with the 
genetics of expression of the ~1 light chain, both in normal immunoglobulin  and in 
the antibody to a(1,3)dextran.  This is the first example we have of a regulatory gene 
linked to the light chain locus which controls specific dominant responsiveness. 
Materials and Methods 
Most of the Materials and Methods have been described in detail elsewhere (5). 
Quantitation of the Light  Chain Class Associated with Antibody to the a(l,3)  and a(l,6)  Glucosyl 
Linkages of B1355.  A  two-stage  radioimmunoassay  (RIA)  was  used  to  quantitate  both the 
* Supported  by grant  R01  AI05875,  awarded  by the Allergy and  Infections Disease Branch of the 
National Institutes of Health. 
x Abbreviations used in this paper: ASC, antigen-sensitive, bone-marrow derived lymphocytes; BSA, bovine 
serum albumin; c~1, constant region of the murine lambda-one light chain, or the structural gene encoding 
it; FITC, fluorescein isothiocyanate; HnRNA, high molecular weight nuclear RNA; Ig, immunogiobulin; 
it  ......  +  ,a)  ,a)  Ig-1 , the a allele oflg-1, which ldenufies a heavy chain gene complex contammgv~  1  genes (v~[  );  Ig- 
b  ,a)  ,8)  1 , the b allele of Ig-1, which identifies a heavy chain gene complex lacking v~l  genes  (v~t  -);  ~, the 
murine kappa light  chain,  defined by  the O-terminal trTpic poptide ALA  ASP  OYS;  ~a, the murine 
lambda-one light chain, defined by the C-terminal trTpic peptide ALA ASP CYS SER; r~  locus, a gene 
locus regulating hi light chain expression; rxl +,  an allele of the hi locus present  in the BALB/c  strain; 
rx~lo, an allele of the ~  locus present in the SJL strain; h2, the murine lambda-two light chain, defined by 
the C-terminal trypic poptide SER LEU SER PRO ALA GLU OYS LEU;  NRS, normal rabbit serum; 
PBSAE, phosphate-buffered saline with  10  -a M  sodium azide and 10  -s M  (ethylenedinitrilo)-tetraacetic 
acid; RIA, radioimmunoassay; v~, variable region of the heavy chain or the structural gene encoding it; 
v~'~  3~, one of several germ-line heavy chain variable regions, or the gene encoding it, which complements 
with vx, to produce a combining site with specificity for the a(l,3) glucosyl linkage; v,, variable region of 
the kappa light chain or the structural gene encoding it;  vL, variable region of the light chain or the 
structural  gene encoding it;  vx,,  variable region of the lambda-one light  chain  or the structural gene 
encoding it;  vx2, variable region  of the  lambda-two light  chain  or  the  structural  gene  encoding it; 
vx~v~  3), the possession  of both a vx~ structural gene and also a v~ a~  set, such that the association of the 
a  lS)  products of the vxt structural and any one of the v~'~  genes produces a combining site with specificity for 
the a(1,3) glucosyl  linkage. 
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fraction of a  B1355 antibody response with specificity for each linkage and also the g:hl ratio 
of the a(1,3) and a(1,6) antibody response. 
B 1355, containing a(1,3) and a(1,6) glucosyl linkages, or B512, which contains a( 1,6) linkages 
are the gift of Dr. Allene Jeanes, Department of Agriculture, Peoria, I11. Each is dissolved to a 
final concentration of 100/~g/ml in phosphate-buffered saline with  10 -3 M  sodium azide and 
10  -3 M  (ethylenedinitrilo)-tetraacetic  acid (PBSAE). 1 ml of either dextran solution is added to 
polystyrene tubes  (Falcon 2052, Falcon Plastics, Oxnard, Calif.) and incubated 4 h  at room 
temperature to allow adsorption of dextran into the tubes. The tubes are washed three times 
with PBSAE and remaining adsorption sites are blocked by a ½ h incubation with 2 ml of 1% 
(wt/vol) bovine serum albumin (BSA) in PBSAE. The anti-B1355 titer of immune test sera is 
estimated by hemagglutination assay. In the first stage of the RIA, an amount of test antiserum 
diluted to 1.1 ml with 1% (wt/vol) BSA in PBSAE is added to two tubes with absorbed B1355 
(a(1,3)  +  a(1,6))  and  to two tubes with adsorbed B512  (a(1,6)  only) such  that  neither the 
a(1,3) nor the a(1,6) binding sites are saturated by the anti-dextran antibody (generally <10 
/xg). For each  test  sera  there  are  now  two  tubes  with  bound  B1355  dextran/anti-dextran 
antibody complexes and two tubes with bound B512 dextran/anti-dextran complexes. 
In the second stage of the RIA, the amount of ~¢- and ha-bearing immunoglobulins in these 
complexes is determined. 125I-labeled  anti-g, diluted to  1.2 ml in  1%  (wt/voi) BSA and 0.1% 
normal rabbit serum  (NRS)  in  PBSAE, is added to one of the two tubes containing either 
dextran/anti-dextran antibody complex. The other tube in each set is likewise incubated with 
126I-labeled anti-h~ antibody. The amount of added anti-light chain is in excess of the amount 
which is capable of binding to the dextran/anti-dextran complex. The second stage of the RIA 
is incubated for 24 h. The tubes are washed three times with PBSAE, dried, and counted for 
125I content. The amount  of 125I-labeled  anti-~ or anti-hi antibody which has bound to each 
dextran/anti-dextran complex is a  function  of the amount  of anti-dextran antibody in  the 
complex. This is quantitated by reference to a standard curve. The standard curve for bound 
hi anti-dextran/12~I-labeled anti-hi is constructed by binding known amounts of purified J558, 
a  hi plasmacytoma antibody with a(1,31specificity, to B1355  dextran in the first stage, and 
subsequently measuring the amount of 12 I-labeled anti-hi antibody bound in the second stage. 
A  standard  curve  is likewise constructed  for bound  K-anti-dextran/l*5I-labeled anti-~ by 
binding known amounts of purified W3129, a K-plasmacytoma antibody with a(1,6)specificity, 
to B512 dextran in the first stage, and subsequently measuring the amount of  I-labeled anti- 
antibody  bound  in  the  second  stage.  The  amount  of antibody  with  a(1,3)specificity is 
calculated by subtracting the amount  of antibody bound to a(1,6)determinants (B512)  from 
the amount bound to a(1,3) and a(1,6)determinants (B1355). 
Preparation of Anti-ldiotypic Antibody.  An anti-idiotypic antibody specific for the combining 
site of anti-a(1,3)dextran antibodies encoded by vxlv~  1 was prepared by immunizing rabbits 
with MOPC  104E  (ha IgM anti-a(1,3)dextran). Most of the anti-hi antibody was removed by 
affinity chromatography of the anti-serum on Y  5431  (hi Bence-Jones) coupled to Sepharose 
4B. The effluent was chromatographed on a Sepharose 4B column to which J558 (hx IgA anti- 
a(1,3)dextran), which idiotypically  cross-reacts with MOPC 104E, was coupled. The acid eluate 
of this column was neutralized and passed over a  Y5606  (hllgGz) Sepharose 4B column to 
remove residual anti-hi activity, and the anti-idiotypic antibody was obtained in the effluent. 
The  binding  of  the  purified  anti-idiotypic  antibody  can  be  specifically  inhibited  by 
a(1,3)containing dextrans. 
Results 
The Amount of ~l-Light Chain Associated with Normal Serum Immunoglobulin is different m 
Various Mouse  Strains.  Among  most  inbred  mouse  strains  there  is  no  more  than  a 
fourfold variation in ~1 levels (Table I). Two inbred strains, however, SJL and BSVS, 
have very low levels of ~1. The reduction in ~1 serum levels is specific for the ~1  light 
chain class since inbred strains with low or high levels of~l have comparable levels of 
the ~-Iight chain in normal serum. 
To demonstrate that strains with very low measured levels of ~1  actually possess a 
finite amount  of ~lIg, portions of SJL normal serum were preincubated with anti-~l 1124  MURINE  ~-1  LIGHT  CHAIN 
TABLE  I 
The Amount of •1  and tc-lmmunoglobulin in Normal Serum of Various Mouse Strains 
Mouse strain  Xllg  x-Ig  )~1 :x 
Itg/ml serum  I~g/ml serum  % 
BALB/c  68.0  4,400  1.5" 
BALB/c (nu/nu)  66.0  --  -- 
SoIL  2.5  7,000  0.035 
SJA9  0.45  --  -- 
BSVS  1.0  3,500  0.028 
BRVR  43.0  --  -- 
(SJLxBSVS) FI  1.8 
B10.D2  88.0  --  -- 
TL-A  84.0  --  -- 
LP  78.0  --  -- 
129  50.0  --  -- 
BI0.BR  48.0  --  -- 
SL  40.0  --  -- 
A/He  39.0  --  -- 
C57L  39.0  --  -- 
CWB  39.0  --  -- 
W/S  39.0  --  -- 
C3H.Q15  28.0  --  -- 
C57BL/6  24.0  3,000  0.80 
RIII  24.0  --  -- 
Determinations were performed by RIA of serum pooled from at least 10 individual mice of both sexes. 
SE __0.03 for all determinations. --, not done. 
* Our  data  show  a  lower  )kl:x-ratio  than  that  reported  in  a  recent  study  (14)  using  radiochemical 
determination of carboxyl-terminal peptides. While this difference does not affect our interpretations of 
the findings, the reason for the discrepancy remains to be clarified. 
coupled  to Sepharose.  Such preincubation  abrogates  by 99%  the ability of the serum 
to compete  in  the RIA  for ~1  (data  not  shown).  We  conclude  that  the low  values of 
)~llg in SJL  and  BSVS  are real  and  that  the )kl  level  in  BALB/c  normal  serum  is 30- 
fold  higher  than  in  SJL.  When  a  comparison  is  made  of )kllg  levels  relative  to  x-Ig 
levels (the)~:r-ratio)  the )~llg level is 50-fold  higher in BALB/c  than  in SJL. 
The Expression  of ~l  is Controlled by a Single Genetic Locus.  To analyze  the genetics of 
the control of~l  expression,  (BALB/c  ×  SJL)F1,  F2, and  F3 progeny  were examined. 
BALB/c  has high levels of)~l and SJL has low levels of)~l. These inbred strains possess 
different  markers  at  the  two  gene  complexes  which  are  known  to  control  specific 
dominant  immune  responsiveness,  the  major  histocompatibility  complex  and  the 
heavy chain complex.  BALB/c  has the H-2 d haplotype  and  the heavy chain complex 
identified by the Ig-1 a allotype. SJL has the H-2  ~ haplotype  and the Ig-1 b allotype  (6). 
(BALB/c  ×  SJL)FI  progeny are phenotypically  ~1  intermediates, i,e., their" average 
)~l  level is one-half that of the )xl  high phenotype  (Results). 
(BALB/c  ×  SJL)F2  progeny  were typed  for their H-2  haplotypes  and  heavy chain 
aliotypes.  The  F2  progeny  homozygous  for  all  combinations  of H-2  haplotype  and 
heavy  chain  aliogroup  were  tested  for N1  serum  levels.  The  results are shown  in  Fig. WILLIAM GECKELER, JEROME  FAVERSHAM, AND MELVIN  COHN  1125 
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Fie.  1.  The amount of )~lIg in the serum of (BALB/c  X  SJL)F2 progeny homozygous for H-2 
haplotypc and heavy chain allogroup. (BALB/c X  SJL)F2 progeny homozygous for H-2 haplotype 
and heavy chain allogroup were tested  for serum levels of ~lIg by RIA. Individuals with less than 
5 #g/ml ~lIg are phenotypically ;kl low  and are postulated to possess the rallO/rx~lo genotype. 
Individuals with greater than 10 #g/ml ~lIg are phenotypically hi intermediate or At high, and are 
postulated to possess the rat +/ra~lo or ra, +/r;~t +  genotype, respectively. 
TABL~  II 
Segregation in the (BALB/c  X  SJL)F2 Generation of the rx~  Locus as a Single Genetic Unit, Unlinked to 
the Major Histocompatibility Complex (H-2) or to the Heavy Chain Allogroup 
Observed ~.1  Postulated  H_2a/alg,,/a H.2d/dlgb/b  H_2./.Ig,/.  H.2./,igb/b 
phenotype  genotype 
Low  rajlo/ra~lo  7  8  6  6 
Intermediate to  ratio/rat +  +  24  26  17  19 
high  r~,  t +/ra~ + 
Number of H-2  and  heavy  chain  allogroup  31  34  23  25 
homozygotes 
An SJL ×  BALB/c mating comprised the parental generation for the genetic segregation study. SJL mice 
are homozygous  rx~lo,  H-2  ~, Ig-I  D. BALB/c mice are homozygous rx~+, H-2  d, Ig-1  l. 512 F2 progeny were 
tested for H-2 haplotype and heavy chain allotype. Individuals homozygous for each combination of H-2 
and allotype were then tested for the level of Xllg in normal serum. Of 512 mice ¼6 (32) are expected to be 
homozygous at both alleles for any combination of H-2 and heavy chain allogroup.  Within each category 
V4 are expected to be r~ulo/rx~lo  and a/4 are expected  to be  r~,~lo/ra~+  plus  rat+/ra~+. 
1 and summarized in Table II. Within each group of H-2 and allogroup homozygotes 
both ;kl interntediate to high phenotypes and also )~j low phenotypes were recovered. 
The ratio of)~l  intermediate to high:~l  low penotypes within each  group was 3: 1. 
The simplest interpretation of the segregation ratios of high and low )~1 phenotypes 
is that  two alleles, ra~+  and rx,lo, at a  single genetic locus, rx,,  control the level of)~l 
light  chain.  Thus,  BALB/c  (rx~+/rx,+)  has  the  ~.1  high  phenotype  and  SJL 
(rx~lo/ra~lo)  has  the ha  low  phenotype.  In  the  F2,  the  genotypes  rx 1 +  /ral  +,  r~,  1 + 
/r~,~lo,  and  rx,lo/ra, io  are  expected  to  distribute  in  a  1:2:1  ratio.  It  is  difficult  to 
distinguish consistently whether an individual is )~l high or )~1 intermediate, since the 
phenotype within each  genotype group  is obscured  by individual variation. On  the 
other hand, it is always possible to distinguish ~.1 low from )~1 high or ;k~ intermediate 1126  MURINE Xa LIGHT CHAIN 
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Fro.  2.  )~lIg  levels  of(BALB/c X SJL)FI individuals measured by RIA. Determinations  of parental 
~.aIg levels are shown for comparison. ~xIg  levels of ,~ALB/c  X C57BL/6)F1 individuals were also 
determined.  C57BL/6, like, SJL, possesses the IG-1 heavy chain allotype. Unlike SJL, however, 
C57BL/6 exhibits the ?,1 high phenotype. A vertical bar represents the mean ~lIg level  for each 
group. 
because the difference is very great. Since the observed 3:1  ratio is found in  all H-2 
haplotype and heavy chain allogroup homozygote classes in the F2, the rx;  locus must 
be unlinked  to either  the  H-2 or the  heavy chain  gene complexes•  Further,  the rx, 
locus is not sex-linked. 
Fz  mice  homozygous  for every combination  of H-2  haplotype  and  heavy chain 
allogroup, and which were postulated because of their phenotypes to be homozygous 
for rx, +  or rx,io, were mated. In all cases, mating pairs possessing the highest X~ levels 
(presumed  rx, +/ra, +) yielded F.~ progeny which were all X1 high, while mating pairs 
chosen as rx,lo/rx, lo yielded F3 progeny all of which were phenotypically X] low. These 
results confirm that  2,t  expression  breeds true and  its controlled  by a  single genetic 
lOCUS. 
7he ~] Locus is Linked to (or Identical with) the Structural Gene Locus  for ~].  In (BALB/c 
×  SJL)F]  progeny the  rxl+  and  rx,lo alleles show a  gene dosage effect. The X2  level 
of (BALB/c  ×  SJL)F]  progeny are  shown  in  Fig.  2.  For  comparison, ;k]  levels of 
(BALB/c  ×  C57BL/6)F]  progeny are also shown. The C57BL/6 strain, like SJL, has 
the  Ig-I  b heavy chain  allogroup,  but  unlike  SJL  expresses  a  high  level  of ;k]. The 
results show that the average level of Xl in (BALB/c  ×  SJL)F] normal immunoglobu- 
lin is one-half the level found in  (BALB/c  ×  C57BL/6)F]  progeny. 
The finding that rx, +/~, 1o heterozygotes have one-half the level of~lIg compared 
to rx, +/rx, +  homozygotes implies either that the r;,, locus is identical to the structural 
gene locus  for X1  or that  the  r;~, locus  is regulatory and  expressed in  cis with  the ~1 
structural  gene and therefore is closely linked to it. This finding will be dealt with in 
the Discussion. 
7he ~  Locus Affects the Antibody Response to the a(1,3)Glucosyl Linkage which is Encoded 
a(1,3)  by the vx]vm]  Genes.  To analyze the mechanism by which  the r~  locus regulates ~1 
light chain expression, mice homozygous for the Ig-1  ~ allotype and either the r;~+  or 
rx~lo allele were immunized with B1355.  It is known that rx] +/va~ +  mice possessing 
r~(1,3) ÷  the  vm,  alleles respond predominantly to the e~(l,3)  glucosyl linkages of B3155  by 
•  a(]  3~  producing an antibody encoded exclusively by the complementing genesvx,vm(  (7). 
+~(1,3)  +  The VHa~  genes are present in the heavy chain gene complex identified by the Ig-1" 
allotypic marker. The  response is  uniformly of high  magnitude  in  individuals  with 
the  r~; +, Ig-l" genotype. BALB/c, one of the parents used in the genetic analysis of 
the r~, locus, possesses this genotype. SJL, the other parent used in the genetic analysis 
,,(Ls)  (linked  to Ig-1 b)  and  would  be a  low  responder to  B1355,  of the  rx,  locus,  is  v~, 
even if it were  rx,+/r;~,+. WILLIAM GEOKELER, JEROME  FAVERSHAM,  AND MELVIN OOHN  1127 
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FIG.  3.  Magnitude of the AI anti-a(1,3)primary response in rx~ +,  Ig-1" and rxilo, Ig- 1" homozygote 
(BALB/c X  SJL)F3 mice measured by a two-stage RIA. (BALB/c X  SJL)Fa mice were allotyped 
and tested for the amount of ~,lIg in their serum. Those classified as homozygous for r~ +, Ig-1"  or 
r~,lo, Ig-1  a were then immunized i.p. with  100 p.g B1355 in PBS and bled 7 days later. Panel A 
represents  the analysis of rx~ +, Ig-1" homozygotes  and panel B represents the analysis ofrx~lo, Ig-1" 
homozygotes. 
(BALB/c ×  SJL)F.~ mice, homozygous for the Ig-1  a heavy chain allotype and either 
the  rx, +  or the  rx, lo allele,  were immunized with B1355. Their ?~-antibody response 
to  the  a(1,3)  glycosyl  linkage  is  shown  in  Fig.  3.  rx, +,  Ig-I  a  homozygotes  give  a 
uniformly  high  response  like  the  BALB/c parental  strain.  Its  magnitude  varies  no 
more than  2.5-fold among individuals.  On  the other hand, rx ,1o,  Ig-1 a homozygotes 
exhibit  great  individual  variation  in  the  magnitude  of their ~  anti-a(1,3)  response. 
From Table III it can be seen that the anti-a(l,3)  response of these rx,lo homozygotes 
can be classified into three groups, high, intermediate,  and low. The antibody of high 
responders  is predominantly  in  the X]  light  chain class.  Intermediate  responders  fall 
into three classes; those whose response is in the ?~i light chain class alone, those whose 
response is in both Al and g-light chain class, and those whose response is only in the 
g-light  chain  class.  The antibody of low  responders  is  predominantly  in  the N-class. 
SJA9 mice, which are congenic with SJL except for the Ig-1 ~ allotype, and thus possess 
rx, lo  and  Ig-I  ~  on  a  uniform  genetic  background,  show  the  same  variability  in 
responsiveness  to  B1355  (R.  Riblet,  personal  communication).  Thus,  the  wide  fluc- 
tuation  in the magnitude of the a(1,3)  dextran  response seen  in  (BALB/c  ×  SJL)F.~ 
mice homozygous for rx,lo and Ig-1 a is unlikely due to genetic loci other than ?~] which 
are still segregating.  Rather it  is due to the  rx,lo allele itself. 
The  rx,lo  allele  generates  the  wide  fluctuation  in  the  magnitude  of the  a(l,3) 
dextran response among rx,lo, Ig-1 ~ homozygotes by a process which acts randomly in 
each  animal.  Thus,  if one  intermates  Fa  rx,lo,  Ig-1  ~ homozygotes  which  were  the 
highest  responders  to  B1355  or the  lowest  responders  to  B3155,  one  finds  that  the 
progeny of either mating exhibit  the same pattern  of wide response variability  (data 
not shown). 1128  MURINE ha  LIGHT CHAIN 
TABLE  III 
Light Chain Class and Determinant Specificity of the Primary Antibody Response to B/355 in ( BA LB/c 
×  SJL)Fa Mice Homozygousfor rx,lo and Ig-l" 
Magnitude of the re-  Magnitude of specific responses  Predominant 
sponse to BI355  light chain class 
| temagglutination  titer  Alanti-  x-anti-  ,~lanti-  x-anti- 
(log2)  0t(1,3)  a(l,3)  0t(1,6)  a(1,6)  of antibody 
Itigh 
#glml 
>11.5  5.52  23  <.5  <5  ~ 
>11.5  475  52  <5  <5  ,~ 
>11.5  328  12  <4  <4  ~ 
10.5  160  19  <4  7  ~] 
Intermediate  8.5  60  6.4  <5  <5  )~ 
7.5  31  1.8  <5  <5  )~ 
8.5  44  20  <3  <3  )~ +  K 
8.5  <1.25  52.5  <1.25  <1.25  K 
8.5  <2.5  65  <2.5  <2.5 
Low  6.0  <2  32  <2  <2  K 
5.0  <3  36  <3  <3  K 
(BALB/c ×  SJL)Fs mice homozygous for rx,lo and lg-l" were immunized i.p. with  100-~g B1355 in PBS. 
7 days later they were bled, and the immune  sera were titered  by hemagglutination  and subsequently 
analyzed for the magnitude of their antibody response to the a(1,3) and a(I,6) determinants  of B1355 as 
well as for the light chain class used in the response to each determinant by a two-stage RIA. 
7he )~lV'l~;  '~)+ Gene Products of  rx, +, Ig- l" and rx, lo, Ig-1" Homozygotes have Indistinguishable 
Ligand-Modifiable Idiotypes,  Le.  Combining Sites.  The rx,+  and rx,lo allele might encode 
two different  v~,  sequences with  different amino acids in  positions which  contribute 
to the binding site specificity. The ra,lo, Ig-l" homozygotes which express infrequent 
high magnitude responses of the a(l,3) specificity produce an antibody which, like all 
rx, +,  Ig-l" homozygotes, possesses the )~1  light-chain as its predominant  component 
(Table III). The idiotypes of these antibodies were compared by RIA for their ability 
"1  ~ (1,3)  to  quantitatively  inhibit  the  binding of ]2'~I-labeled J558,  a  ,,]vtv,,  plasmacytoma 
antibody with a(l,3)  specificity, to a  purified, ligand-modifiable, anti-idiotypic anti- 
body. The  results  (Fig. 4)  indicate that  the combining site idiotypes of the X~"v~i  '~ 
i+  atl,3)  and a] vHxl  antibodies are indistinguishable. That small changes in either thev~,  or 
v~',  3)  contribution  to  the  combining  site  specificity are  detectable  by  this  assay  is 
suggested  by  several  findings.  First,  it  has  been  shown  that  reconstruction  of  a 
nongerm-line ~1  light chain  possessing amino acid substitutions in complementarity- 
determining regions with a  v~i~,  ''s) heavy chain can produce an a(l,3)  antibody whose 
altered  combining site can  be  discriminated by  this  kind  of assay  (7).  Second,  this 
assay  discriminates  between  .1558  and  MOPC  104E  idiotypes  (Fig.  4).  These  plas- 
macytoma  antibodies with  or(l,3)  specificity have  identical ~]  light  chains  with  the 
¢~ (1,3)  germ-like sequence and apparently closely related VH~,  amino acid sequences which 
are identical through  the 30 amino-terminal residues which  have been sequenced  (L. 
Hood, personal communication). 
7he r~,  Locus Exerts its EJfect in the Stem (,ell before B-Cell Expression.  The stage of B- 
cell differentiation at which  the rx,  locus exerts its effect was determined by enumer- 
ating )~rbearing cells in spleens ofrx~lo and ra, +  homozygotes by staining cell surface WILLIAM  GECKELER, JEROME  FAVERSHAM,  AND  MELVIN  COHN  1129 
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kl  HA I 
FiG.  4.  The Alv.,~;  8)÷ encoded a(1,3) antibodies of r×,+,  Ig-1 a andre,  In,  Ig-l" homozygotes possess 
indistinguishable ligand-modifiable idiotypes. Immune sera from individual  (BALB/c  ×  SJL)Fa 
mice homozygous for n.  1  +,  Ig-1  j or razlo, Ig-1" which gave a high magnitude response to the a(1,3) 
glucosyl  determinant  in  the  AI  light  chain  class  were  adjusted  to  the  same  a(1,3)  antibody 
concentration.  They  were  then  serially  diluted,  and  used  as  competitors  in  the  RIA  for  the 
vx,v~;  '~) combining site idiotype. J558  (AtlgA anti-a(],3))  and  MOP(]  104E  (AIIgM anti-a(I,3)) 
were adjusted to the same concentration, serially diluted, and used as competitors in a  RIA for the 
v~.j,~;  s) combining site idiotype. The anti-idiotypic antibody in the solid phase recognizes cross- 
reactive  determinants of the J558  and  MOP(]  104E  idiotypes.  The  ~I-labeled  probe  is J558. 
Competition by O  n,  tlo v~ 3)  antibody, •  r~.~  +  v~'~  ~)  antibody,  ×  unlabeled J558,  +  unlabeled 
MOPC  104E. 
TABLE IV 
Frequency of Splenic Lymphocytes Expressing  K- or ×1-Light Chains 
Percent viable cells staining with: 
Anti-x  Anti-A1 
BALB/c  43  (65/152)*  0.60  (6/960) 
(BALB/c  ×  SJI,)F,  --$  0.24  (5/2,080) 
SJL  59 (136/231)  0.018 (2/1.14  ×  104) 
Spleen cells pooled from five individual BALB/c, (BALB/c  X  SJL)FI, or SJL mice were stained with 
FITC-conjugated  anti-•  or anti-Al.  Dead  cells were identified by ethidium  bromide staining.  Viable 
lymphocytes stained with either FITC-conjugated anti-light chain were enumerated by examining each 
field at 945-fold magnification using alternate filter combinations. 
* (Viable, FITC-positive cells/total viable cells examined). 
$ Not done. 
immunogiobulins with a fluorescent anti-X]  reagent. The frequency of~]-bearing cells 
in  the  spleens  of rx,lo/rx,lo  homozygotes  is  reduced  nearly  30-fold  compared  to 
Ix, +/ra~ +  homozygotes, while the number of K-bearing spleen cells is comparable in 
both  (Table IV). rx, +/rx,lo heterozygotes have about one-half as many )~]-bearing 
cells as rx,+/ra, +  homozygotes. The results can be used to argue that the ra,  locus 
exerts its effect during a stage of B-cell differentiation which precedes the appearance 
of antigen-sensitive B cells  (Discussion). 
Discussion 
The ra,  Locus is Linked to  (or Identical with)  the vx,  or ca,  Structural Gene.  The primary 
measurable effect of the ratio allele is to reduce the frequency of A1 ASCs by a  factor 
of 50.  However,  these  ~1  ASCs  expressed  by rallo  homozygotes are  functionally 1130  MURINE hi  LIGHT CHAIN 
equivalent to those expressed by rxj +.  Thus, for instance, about  30% of rx, 1o, Ig-I a 
homozygous individuals give a primary hi anti-a(1,3) dextran response of a magnitude 
and idiotype indistinguishable  from rxa +, Ig'l a homozygotes (Figs.  3 and 4). In the 
heterozygous rx~lo/rx 1  +  there are one-half as many ha ASCs as in homozygous rx~ + 
individuals, i.e. there is a gene dosage effect. 
This effect of the rxllo allele cannot be accounted for at the level of protein structure, 
translocation,  or  transcription.  Any  such  explanation  would  predict  a  functional 
impairment of every cell expressing hi. For example, the ratio allele cannot act at the 
level of efficiency of induction or of function of the induced plasmacytes. Such effects 
would  be  revealed  by  finding  a  normal  number  of hi  ASCs  induced  to  become 
plasmacytes inefficiently. Since this is not found the rx~lo allele must control an event 
which manifests itself at the DNA level. In an rxalo homozygote, the normal expression 
of hi in a rare ASC could be due either to somatic reversion of a germ-like mutation 
or to regulation. 
First, what kinds of somatic mutational events could account for the rxllo pheno- 
type? The rXllO allele could be either a single-base mutation in a regulatory element 
controlling translocation or transcription, a  nonsense mutation in the rxl structural 
gene which  results  in  a  premature  termination  of hi  light  chain  translation,  or a 
missense  mutation  in  the  vxa structural  gene which  could conceivably destroy the 
ability of the vxa product to form a  functional domain with any vn product. In all 
these examples, the observed expression of the hi light chain in rXllO homozygotes is 
accounted for by somatic mutational reversion to wild-type in the stem-cell popula- 
tion. The reversions would not necessarily be detectable as changes in the amino acid 
sequences of hi. As examples, a reversion in a mutant regulatory element would not 
be translated during hi light chain synthesis. A reversion in a nonsense codon in that 
region of DNA encoding the ha amino-terminal precursor piece would be translated 
but not detected because it is cleaved from the hx light chain (8). 
We can approximate (9) what the mutation rate must be to generate the steady- 
state  number  of hi-bearing  ASCs  enumerated  by  fluorescent  anti-ha  cell  surface 
staining of rxllo homozygote splenic lymphocytes. IfNis the number of rapid-dividing, 
short-lived cells which generate the immune system, # is the number of divisions these 
cells undergo per day, and a is the probability of a mutation at the appropriate base 
pair during each cell division, then functional revertants will be produced at a daily 
rate given by dM/dt  =  0.69 a#N. In the mature immune system of a rx 11o homozygote 
there are ~104 hl ASC$ (Table V), and the immune system appears in t ~  20 days, so 
dM/dt ~5  ×  10  z revertants/day. N is taken to be on the order of 107 cells, since the 
steady-state adult B lymphocyte population is no larger than 2  X  10  s cells. Thus, a 
the mutation rate/base pair/division would have to be approximately 2.5  X  10  -5. 
Since, the absence of repair, the maximum rate per base pair per division for bacterial 
systems has been reported to be  10  -7  (discussed in  [10]), this class of models seems 
unlikely. 
Second, what  kinds of regulatory mechanisms could account for the rxllo allele? 
The fact that in rx,lo/~ +  heterozygotes the number of rxl ASCs is one-half of that 
found  in  rxl+/rx  1 +  requires  that  the  ral  regulatory gene  be  expressed  allelically 
excluded like the va  1 structural gene. If it were unlinked to the ha structural gene it is 
unlikely that it would be expressed allelically excluded. Hence, we assume that it is 
expressed in cis to the hx structural gene and is linked to it. As a consequence of allelic 
exclusion, the  rxjlo/rx, +  heterozygote would  express only one of the  parental  loci WILLIAM GECKELER, JEROME  FAVERSHAM, AND MELVIN COHN  1  131 
TAnLE V 
A Summary of the Effect of the rxa+ and rxalo Alleles on the )~1 ASC Population and on the Expression of 
hi Immunoglobulin 
Relative 
Relative 
Total ~.1  v),, v~t,{~  ratio 
Inbred strain  Genotype  ASCs/  ASCs/  ~ASCs§  ratio  ~Ig  ~aASCs  (%  total Ig)  ~:x-light 
spleen*  spleen:~  (SJL ~  1)  chain 
($JL-  1) 
% 
BALB/c  rx, + r~ +  v~,~'/v~'~;  s~  2.5  X  10  s  2.5  x  10  s  1.4  52  1.5  54 
(BALB/c  X  SJL)FI  rx~+/rx, lo  v[g{iS+/v~'~l  s-  10  ~  --  --  21§  --  23ll 
SJL  D,  tlo/rx~lo  v~f~a-  / v~:~i  s-  10  ~  --  0.027  1  0.028  1 
SJA~  r~,~lo/r~.~lo  v~.~;s'/v~~i ~  --  10  z  .... 
* Calculated from Table IV, assuming .5  ×  l07 ASCs/spleen. 
:~ Based on the estimate of 1  v~/~gene/102 total VH gene (18). 
§ Calculated  from Table  IV, assuming that  all ASCs stain  with one of the  FITC-conjugated i¢- or ~1 antibodies.  (BALB/c  ×  SJL)FI are 
assumed to have the same number of x-ASCs as BALB/c. 
U  Data from Table I. (BALB/c  ×  SJL)F~ are assumed to have the same amount ofx-lg in normal serum as BALB/c. 
-- not done. 
randomly in each ASC. The result would be a  gene dosage effect because the stem 
cell expressing the rXllO allele would have a low probability of becoming a functional 
)~x ASC while the stem cell expressing the rx  I +  allele would have a high probability 
of becoming a functional )~1 ASC. 
What  Regulatory  Function  Might  the  rx 1 Locus  Encode?  An  acceptable  model  must 
account for the finding that, in rxllo homozygotes, the rx~lo allele greatly reduces the 
number of )~1 ASCs but the few X1 ASCs present express a  functional )~1 light chain 
indistinguishable  from wild-type. In one such molecular level model the rallo allele 
represents a  single base change in a  DNA palindrome involved in the translocation 
event which makes the 5'-end of the vxl gene and the 3'-end of the intron-ca  1 gene 
contiguous (11-13). This single base change would reduce the probability that a DNA 
endonuclease will nick one of the palindrome sites required for successful translocation. 
Consider a  heterozygous stem cell, ral +/r~ 11o, which is undergoing differentiation 
to a  B  cell expressing the )~1 light  chain.  Initially the  stem  cell undergoes alleleic 
exclusion  and  translocation of vx~  to  intron-ca  v  If the  ral +  allele is  expressed  the 
palindromic sequences are nicked with 100% probability and successful translocation 
occurs.  If the  rXllO allele  is  expressed,  endonuclease  nicking  and  translocation  is 
successful with only 2% probability. The unsuccessful cells committed to )~x expression 
never synthesize a  light chain and thus never express an immunoglobulin receptor. 
Consequently, the overall probability that translocation in the heterozygote will occur 
successfully  is  51%.  The  ratio  of  antigen-sensitive  cells  which  express  )~1  in 
rx~ +/rx~ +, rx, +/ratio, and ratlo/ra, lo mice should be 100:51:2, respectively, and that 
is the case (Table V). Once a cell has undergone successful translocation and expresses 
~1, whether it is rx~lo or ra~+, it functions equally well. 
In this regard, it should be noted that although the )h and 2~2 light chain class are 
probably each coded for by one v and one c gene, the ~1:~2 ratio in normal Ig is 4:1 
(14).  The  difference in  expression  could  be  accounted  for by a  difference in  the 
efficiency of translocation for ~x and ~2. Such a model would predict that the 5'-v or 
the  3'-intron-c  palindromes  are  different  for  ~x  and  ~2,  but  they  use  the  same 
endonuclease. We are aware of alternative explanations. For example, it may be that 
)~1  and  )~2  are  translocated  at  the  same  frequency and  expressed with  a  different 
average family of vns in ASCs,  and that the expression of )~1 with its vn repertoire 1132  MURINE  )h  LIGHT  CHAIN 
TABLE  VI 
The Distribution in the Magnitude of the Anti-a(1,3) Response in the )~1 Class of  rx,lo VHX~'~-l"a+ 
Homozygotes Fits a Poisson Distribution 
Fraction of sample 
with an actual 
number of respond- 
ing units, r 
Predicted distribu- 
tion for an average 
number of respond- 
ing units, m  ffi  1.6 
Observed distribution for the magnitude of 
valv~  a) responsiveness* 
r  ffi  Fraction of sample  Fraction of sample  Response range 
ffg/rnl 
0  0.20  0.21  (5/24)  0  (<5) 
1  0.32  0.33 (8/24)  5-150 
2  0.26  0.25 (6/24)  151-300 
3  0.14  0.13 (3/24)  301-450 
4  0.05  0.04 (1/24)  450-600 
5  0.02  <0.04 (0/24)  >600 
*Data from Fig. 3B. 
may produce more antigen-binding specificities than the corresponding ~2vn combi- 
nations.  In that case the 4:1  ratio of ~,1/)k2 in normal Ig would reflect a  preferential 
antigenic selection for ~xva combinations. 
The Regulation of a Specific Antibody Response  in the )kl Class by the rxl Locus.  In animals 
possessing the responder heavy chain locus (V~'l  3)÷), the rx~ 1o homozygotes shows wide 
fluctuations  in  the  magnitude  of the  anti-a(1,3)  dextran  response,  while  the rxl + 
homozygote shows a uniform, high ha anti-a(1,3)  dextran response. Since the effect of 
the rxllo allele is to reduce the number of hi-bearing ASCs, it is reasonable to assume 
that  the  variability  in  the  response  of rhlo  v~ 3)  homozygotes  is  due  to  a  large 
variance in the distribution  of ASCs expressing vx~vh~f  ) per individual.  Since it was 
found that the rx~lo allele reduces the number of vx~v~  3~ ASCs such that there exist 
responder and nonresponder individuals, one can assume that the fluctuation follows 
a  Poisson  distribution  and  calculate  the  average number  of responding  units  per 
individual. 
If the average number of responding units per individual is m, then the probability, 
P, that any individual will actually possess a  particular number of responding units, 
me  -m 
r,  is given by the Poisson distribution  p(r)  ffi  r!  The value of rn for rx  1  lo ~11'3) 
homozygotes can  be calculated  from the  fraction of the  sample that  fail to  give a 
va~v~'~  s)  primary response to a(1,3)  dextran  (Fig.  3).  The fraction of nonresponders, 
ro,  is  0.208.  For ro,  p(ro)  =  e -m, so  the  average number of responding  units  per 
individual  m  --  1.6. If it is assumed that within limits, the level of antibody in a  7- 
day primary response is proportional to the number of responding units that animal 
possesses at  the  moment  of immunization,  then  the  response in  individuals  which 
respond may be compared to the theoretical distribution expected when m  ffi  1.6. For 
this comparison the magnitude of the responses was divided into five equal ranges, 
and the fraction of the total sample which fell within each range was computed. The 
actual  distribution  in  the  magnitude  of responsiveness  fits  the  predicted  Poisson 
distribution  for m  --  1.6 quite closely (Table VI). 
The number of ASCs which express vx~v~-x~;  s) and correspond to one responding unit 
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(Table V)  by the average number of responding units. Hence, one responding unit 
corresponds to (102 +  1.6) ~50 ASCs.  Since the total number of ha ASCs is 50-fold 
higher in wild-type rx: +  homozygotes than in rallo (Table V), both the number of 
responding units and also the number of ASCs for vxlv~  a)  should be increased 50- 
fold. Thus, for the wild-type, m  --  (1.6 ×  50) ~80 responding units and there are (80 
responding units  X  50 ASCs/responding unit)  ~4  X  10  a ASCs expressing vx~v~l~  s). 
In fact, over 100 rx~+v~'~  a)+  individuals  have been immunized with a(1,3)  dextran 
(Fig. 3, partial data shown) and no nonresponders have been found. 
If the number of wild-type valve;  a)  ASCs  is  typical of any particular germ-line 
vgvn combination and there are about 104 VLVn germ-like combinations (15), then the 
total number of ASCs per individual would be (4  ×  10  a) (104) ~4  ×  107. Of 4  ×  107 
ASCs  with  germ-line encoded  VLVH, only about  4  X  105  will  express specificities 
selected upon during germ-line evolution. The others are starting points for somatic 
evolution (16). 
The  Regulation of Normal Immunoglobulin in  the  hx  Class by  the rxl  Locus.  Another 
phenotypic effect of the r~  locus which must be accounted for in terms of different 
numbers of hrbearing ASCs in the regulation of the level of hi associated with normal 
immunoglobulin in r~ +  and  rxflo homozygotes. The analysis rests on two observa- 
tions.  The first  observation  is  that  for ra~ +  homozygotes the  ratio of ha:x-bearing 
ASCs determined by spleen cell staining with fluorescent labeled anti-r or anti-hi is 
the same  as  the ratio of hl:x light  chains associated with  normal  immunoglobulin 
(Table V). 
Thus, in ra, +  homozygotes the observed fraction of ASCs which express hi is 1/70 
and  the  observed  fraction of hi  light  chain  in  normal  serum  is  1/65.  The second 
observation is that the ratio of the vx, gene to the total VL gene pool has been estimated 
by an in dependent analysis of  sequences to have a mean value of -  1  / 100 (1/60-1 /260) 
(15). 
The ratio of ~a/K in virgin ASCs represents the probability of expression of the va~ 
gene relative to the total VL pool. Since this ratio is the same as the ratio ofva~/v~ 
germ-line genes, the probability of expression of each VL gene is, on an average, the 
same. This means that the ra, +  regulatory gene operates with the same efficiency as 
an  average  r~+  regulatory  gene.  The  ratio  of hl/K  in  serum  Ig  represents  the 
probability of induction of a given hi ASC relative to a ~¢-ASC. Since this ratio is the 
same as  the  ratio of ~l/r  ASCs,  the  probability of induction  by the  immunogenic 
universe is the same for any given class of ASC  defined as expressing a  unique VL 
framework (subgroup)  (15,  16). The rx,lo mutation  (as well as the rxmlo-like behavior 
of the h2 gene) stresses that for any given germ-line v gene a subtle modulation of the 
frequency of its expression can be imposed by evolutionary selection. This is why we 
discuss the above ratios by referring to an average efficiency expression of germ-line 
v~-genes. 
The gene dosage expression of hi poses a paradox, for it is not immediately obvious 
that  the level of serum ~lIg should depend strictly on the number of ASCs initially 
expressing ha. The ratio of hi-bearing ASCs in ra~lo/rx~lo:rx~lo/rx~  + :ra~ +/rx~ +  geno- 
types is the same as the ratio of  hi light chains associated with normal immunoglobulin 
in  each genotype, and  is approximately  1:25:50.  Clearly, the vx~vH repertoires in  a 
ra~ +/ra, +  homozygote and a ra~lo/ra~ +  heterozygote must be the same. If feedback 
inhibition  by antibody  itself limits  the  level of a  response  any  gene  dosage  effect 
should be masked. 1134  MURINE hi LIGHT CHAIN 
One solution might  be considered. The response to an  immunogen of any given 
class of ASC  (defined by the VL framework it expresses) depends on the number of 
mutational steps it must undergo to recognize the antigen. Those requiring few steps 
are more likely to respond. As the number of a given class of ASC is reduced the total 
number  of possible  somatic  derivatives  generated  from  it  is  reduced.  In  such  a 
situation, an ASC class which might require more mutational steps becomes compet- 
itive in response to an immunogen. Thus, in the rx,lo homozygotes, ASCs expressing 
various V,  VH combinations replace the lost ASCs which would have expressed vxjvn 
combinations. These vKvn ASC replacements become inducible by the determinants 
in  the  antigenic  universe  which  preferentially would  have  induced  their  missing 
va,vH counterparts. This conclusion is supported by a study (17)  with the 0t-locus in 
rabbits. Suppression of the expression of r  by the use of anti-allotypic sera leads to a 
compensatory increase in the level of immunoglobulin bearing a  light chain lacking 
the given allotypic marker (probably ~). 
Is the Regulatory Gene Marked by the rallo Allele an Example of an Element Controlling the 
Expression of an  Entire  Light  Chain (Translocon)  or of a  Single v-Gene?  Since  the  hi 
translocon consists of only one v-gene, this question is unresolved. Given that the ratio 
of hl/r ASC, serum Ig, and germ-line v-genes is -1/100, two modes of expression of 
vL-genes  are reasonable. If the rat gene regulates expession of the ~1 translocon then 
the  stem  cell  first  decides  which  translocon  to  activate,  )kl  or  p¢,  after  which  the 
activated translocon expresses sequentially all of its v-genes. Such a mode of expression 
would make the ratio of)kl/I¢ ASCs equal the vat/v, germ-line gene ratio only if each 
transiocon  were  initially  chosen  with  equal  probability  and  if subsequently  each 
translocon could count its v-gene repertoire by expressing sequentially each v-gene in 
the translocon at each cell division. The ra~lo allele could act to reduce the probability 
that  the ~1  translocon was chosen for activation. The bas mutation  in  rabbits  (18), 
which results in the specific loss of the tt-light-chain class, might represent a defect in 
translocon expression. 
Alternatively, if the rx~ gene regulates expression of a unique v-gene then the stem 
cell could simply activate vc-genes randomly, treating va~ and v, indifferentially. This 
latter mode of expression also would make the ~1/K ratio in ASCs equal to the va,/v, 
germ-line gene ratio.  The model  for the action of the ra~lo allele presented earlier 
exemplifies regulation of a  unique v-gene. While regulation of translocon expression 
or individual  v-gene expression has been presented as alternative interpretations of 
the rxtlo allele, it is probable that both types of regulatory genes operate and that we 
have revealed by the  ra~o allele only one of them. 
Do Regulatory Genes of the rx,-Type  Operate to Control the Expression of the Heavy Chain 
Class?  Only with special assumptions is our analysis applicable to the heavy chain 
translocon  because,  unlike  the  light  chain  translocon,  the  same  set  of vH-genes  is 
expressed with a family of some  10 cH-genes. The general rule is that the suppression 
of one allele does not lead to a compensatory increase in the expression of the other 
allele. This has been shown for murine hi (this paper), rabbit-x (17) and murine ")¢G2a 
(19).  If there is a compensatory increase it appears to come from the other classes, x 
for murine hi, h  for rabbit K and an unknown yG class for murine ~2a. This implies 
that  the choice of class is determined by regulatory genes functioning in the B cell 
itself and not by genes regulating intercellular events, e.g. effective level of cooperative 
activity, secretion of hormones, homing patterns, etc. In other words, the heavy chain WILLIAM GECKELER, JEROME  FAVERSHAM, AND MELVIN COHN  1135 
class which a  given B cell will be committed to express is determined by regulatory 
genes acting intracellularly, not by those acting intercellularly; the assumption being 
that  a  selective  intercellular  mechanism  determining  class  would  he  unable  to 
distinguish cn-alleles. Normally, the level would be determined by the proportion of 
B cells committed to express a  given allele or class of heavy chain. The intercellular 
signals  for commitment  (including the antigen-dependent ones)  determine the fre- 
quency of the  switch  from  [IgM  +  IgD]  to other classes  (20),  not  which  class  is 
expressed. Once switched, induction by antigen selects B cells on the basis of their 
combining  site,  not  the  class  of immunoglobulin  they  express.  This  argument  is 
strongest for the IgG classes and the extent to which it can be applied to IgA and IgE 
is open. 
The existence of such an intracellularly acting regulatory gene has been implied by 
several studies (21) in which the level of a given class of heavy chain is associated with 
the allotype. This suggests both linkage and cis action between the regulatory gene 
and the structural gene determining allotype. If our assumptions are correct, then the 
expression of both heavy and  light chain classes have in common an  intracellular 
mechanism involving a regulatory gene of the  ra ~-type. 
Summary 
We describe here two alleles, an  allele of the ~1 locus present  in  the SJL strain 
(rx,lo) and an allele of the ~a locus present in the BALB/c strain (ra  1  +), of a regulatory 
gene locus which specifically influences the expression of the  mouse ~1  light  chain 
structural gene. The rxa regulatory gene is not linked to either the major histoeom- 
patibility complex or to the heavy-chain allogroup but appears to be linked to the 
1~1 structural gene locus. 
In the homozygous state, the present of the rxllo allele results in a 50-fold reduction 
in  the  number  of ha  antigen-sensitive,  bone-marrow  derived  lymphocytes  (ASCs) 
compared to the presence of the rx~ +  allele. However, those few ~aASCs present in 
ra, lo homozygotes can be induced normally to produce ~1 light chains indistinguish- 
able from those found in rx~ +  homozygotes. The reduction in ?~aASC's due to the 
rx~lo allele results both in a reduction in the amount of?~l Ig in the serum and also in 
a  large variation in the magnitude of the )~x antibody response to a(1,3)  dextran by 
individual animals.  This variation permits the estimate that, on the average, 50 B 
cells of anti-a(1,3)  specificity must  be present  per animal  to permit  a  measurable 
response. 
Surprisingly, the expression of a  gene locus regulating )~1 light  chain  expression 
(r~ locus)  shows a  clear gene dosage effect with rx~ lo/r~ +  heterozygotes having ½ 
the number of)~lASCs and ½ the amount of serum ~l Ig as rx~ +/ra~ +  homozygotes. 
This fact permits an analysis of the relationship between germ-line v-genes and their 
individual expression in serum Ig. 
The rx~ locus controls specifically a  DNA-level event which occurs in stem cells as 
they become committed to ~  light chain expression. We postulate that the ral  locus 
represents one of the DNA level recognition sites involved in the translocation event 
which places the vx, and ca, structural genes in a transcriptional unit. 
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